Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):E803-12. doi: 10.1073/pnas.1103423108. Epub 2011 Aug 22.
Gene expression networks are complicated by the assortment of regulatory factors that bind DNA and modulate transcription combinatorially. Single-cell measurements can reveal biological mechanisms hidden by population averages, but their value has not been fully explored in the context of mRNA regulation. Here, we adapted a single-cell expression profiling technique to examine the gene expression program downstream of Forkhead box O (FOXO) transcription factors during 3D breast epithelial acinar morphogenesis. By analyzing patterns of mRNA fluctuations among individual matrix-attached epithelial cells, we found that a subset of FOXO target genes was jointly regulated by the transcription factor Runt-related transcription factor 1 (RUNX1). Knockdown of RUNX1 causes hyperproliferation and abnormal morphogenesis, both of which require normal FOXO function. Down-regulating RUNX1 and FOXOs simultaneously causes widespread oxidative stress, which arrests proliferation and restores normal acinar morphology. In hormone-negative breast cancers lacking human epidermal growth factor receptor 2 (HER2) amplification, we find that RUNX1 down-regulation is strongly associated with up-regulation of FOXO1, which may be required to support growth of RUNX1-negative tumors. The coordinate function of these two tumor suppressors may provide a failsafe mechanism that inhibits cancer progression.
基因表达网络非常复杂,因为有各种各样的调节因子结合 DNA 并进行组合式转录调控。单细胞测量可以揭示群体平均值所隐藏的生物学机制,但在 mRNA 调控的背景下,其价值尚未得到充分探索。在这里,我们改编了一种单细胞表达谱分析技术,以研究 Forkhead box O (FOXO) 转录因子在三维乳腺上皮细胞腺泡形态发生过程中对下游基因表达程序的影响。通过分析单个基质附着上皮细胞中 mRNA 波动的模式,我们发现一组 FOXO 靶基因受到转录因子 Runt-related transcription factor 1 (RUNX1) 的共同调控。RUNX1 的敲低会导致细胞过度增殖和异常形态发生,这两者都需要正常的 FOXO 功能。同时下调 RUNX1 和 FOXOs 会导致广泛的氧化应激,从而阻止增殖并恢复正常的腺泡形态。在缺乏人表皮生长因子受体 2 (HER2) 扩增的激素阴性乳腺癌中,我们发现 RUNX1 的下调与 FOXO1 的上调强烈相关,这可能是支持 RUNX1 阴性肿瘤生长所必需的。这两种肿瘤抑制因子的协调功能可能提供了一种失效安全机制,抑制癌症进展。